Heparin-Induced Thrombocytopenia Caused by Preventive Anticoagulation After Femoral Intertrochanteric Fracture Surgery: a Case Report

被引:3
|
作者
Hou, Jianwen [1 ]
Liu, Qian [2 ]
Gao, Chong [1 ]
Jia, Xuejun [1 ]
Yang, Fumeng [2 ]
机构
[1] Bengbu Med Coll, Dept Trauma Orthoped, Peoples Hosp Lianyungang 2, Lianyungang, Peoples R China
[2] Bengbu Med Coll, Peoples Hosp Lianyungang 2, Dept Lab Med, 41 East Hailian Rd, Bengbu 222006, Peoples R China
关键词
intertrochanteric fracture; heparin-induced thrombocytopenia; fondaparinux; case report; MANAGEMENT; FONDAPARINUX; PATIENT; HIP;
D O I
10.7754/Clin.Lab.2021.210714
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Heparin-induced thrombocytopenia (HIT) is a severe complication caused by heparin. It is characterized by occult onset and missed diagnosis. Misdiagnosis easily occurs. Methods: This paper reported an 85-year-old woman with an intertrochanteric fracture of the femur which was treated with low molecular weight heparin (LMWH) and fondaparinux sodium to prevent venous thrombosis. Then, the patient developed HIT. This is the first case report of HIT induced by LMWH and fondaparinux in a patient with a hip fracture. This case highlights the severity of HIT in elderly patients with hip fractures using LMWH and fondaparinux and the need for platelet monitoring in these patients. Results: LMWH was ceased in this HIT-confirmed patient, and non-heparin treatment was begun instead. Apixaban was given twice daily for therapeutic anticoagulation therapy. In the end, the platelet levels gradually returned to normal. Conclusions: We should pay more attention to HIT and platelets during the perioperative period of orthopedic surgery, especially in elderly patients. Once the disease is confirmed, it is necessary to stop heparin-related drugs immediately and administer oral anticoagulants instead.
引用
收藏
页码:824 / 828
页数:5
相关论文
共 50 条
  • [22] Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature
    Ezekwudo, Daniel E.
    Chacko, Rebecca
    Gbadamosi, Bolanle
    Batool, Syeda
    Gaikazian, Sussana
    Warkentin, Theodore E.
    Sheppard, Jo-Ann I.
    Jaiyesimi, Ishmael
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [23] Heparin-induced thrombocytopenia during anticoagulation therapy for COVID-19-related pulmonary embolism: A case report
    Zhang, Yu
    Chen, Zhenling
    Li, Jianying
    Wang, Xuejing
    Liu, Yi
    MEDICINE, 2024, 103 (49)
  • [24] Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
    Zhong, Han
    Zhu, Ming-Li
    Yu, Yue-Tian
    Li, Wen
    Xing, Shun-Peng
    Zhao, Xian-Yuan
    Wang, Wei-Jun
    Gu, Zhi-Chun
    Gao, Yuan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [25] Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventions
    Joost, Alexander
    Kurowski, Volkhard
    Radke, Peter W.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (12) : 1176 - 1185
  • [26] Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia
    Tuleja, Aleksandra
    Salvador, Dante
    Muka, Taulant
    Bernhard, Sarah
    Lenz, Armando
    Baumgartner, Iris
    Schindewolf, Marc
    BLOOD ADVANCES, 2022, 6 (10) : 3114 - 3125
  • [27] Successful pregnancy after pulmonary embolism and heparin-induced thrombocytopenia - case report
    Plesinac, S.
    Babovic, I.
    Karapandzic, V. Plesinac
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2013, 40 (02): : 307 - 308
  • [28] Heparin-induced thrombocytopenia in cardiac surgery
    Ljajikj, Edis
    Morshuis, Michiel
    Koster, Andreas
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2020, 34 (01): : 15 - 23
  • [29] Heparin-induced thrombocytopenia and cardiovascular surgery
    Pishko, Allyson M.
    Cuker, Adam
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 536 - 544